Huber’s market growth at is being supported by doubling the production capacity at the Offenburg production site. Construction work on new production facilities and an administration building have already started. Furthermore, the Supervisory Board of Peter Huber Kältemaschinenbau AG agreed to and adopted the suggestion of the Board to acquire the company “Van-der-Heijden Labortechnik GmbH”.....
Automated Workflows Open New Avenues in the Rapidly-Expanding Epigenetic Frontier
Hamilton Robotics and Zymo Research Corporation announced an ongoing collaboration that unites Zymo Research’s epigenetics innovations with Hamilton’s high-throughput workflow expertise. A number of Zymo Research assay chemistries are now optimized for use on Hamilton’s automated liquid handling workstations....
The preparative and process chromatography market is expected to reach $8,950 million by 2019 from $6351.5 million in 2014, at a CAGR of 7.1%.
The global Preparative and Process Chromatography market is categorized on the basis of products and services, end user, and geography. The service segment is expected to register the highest growth rate in the Preparative and Process Chromatography market, by products and services, during the forecast period....
Investment will drive adoption of new diagnostic modality within healthcare system
Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced an investment from Aviva Ventures, the venture capital arm of Aviva plc, a global leader in insurance. The investment takes Owlstone Medical’s total funding to $23.5 million USD (£19.3 million GBP) since its spin-out from Owlstone Inc in 2016....
Lophius Biosciences GmbH today announced the extension of the first tranche of the recently closed financing round by €5.2m to €7.4m
Lophius Biosciences GmbH today announced the extension of the first tranche of the recently closed financing round by €5.2m to €7.4m. The extension round was led by VRD GmbH, one of the current main investors, supported by the Bavarian Growth Fund (“Wachstumsfonds Bayern”) of Bayern Kapital GmbH and the private investor Wolf Biotech GmbH....
New facilities will enable high quality and high throughput Biomarker Services, for identification of novel breath biomarkers in disease diagnostics and precision medicine applications
Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, welcomed Tony Blair to its headquarters in Cambridge, UK where he officially opened the company’s new high volume clinical laboratory. During the visit, Mr Blair learned more about the company’s Breath Biopsy® technology and its mission to save 100,000 lives and $1.5 billion in healthcare costs....
Charnwood Campus and University of Leicester to inspire discovery, encourage collaboration and accelerate business growth for the Med-Tech and Biopharma community
Together with the site owners, Charnwood Campus, and the Leicester and Leicestershire Enterprise Partnership, the University of Leicester is seeking to establish a new Innovation Centre at the UK’s first ever Life Sciences Opportunity Zone in Charnwood, near Loughborough, to accelerate business growth for the Med-Tech and Biopharma community....
Horizon Discovery Group plc has announced it has entered into a research and development collaboration and license agreement with AmplyCell S.A., to evaluate the impact of AmplyCell’s BOOST cell line optimisation technology on Horizon’s parental GS (glutamine synthetase) null CHO K1 cell line.
AmplyCell's Cell Fitness Technologies, which include BOOST, consist of a four-stage process to optimise cell lines in terms of stability and productivity. Cell lines can be stimulated using AmplyCell's Cell Fitness Technologies at any stage of cell line development or bioproduction (clone creation, RCB/DCB, MCB), without the need to change culture conditions.
TSX Series blood bank refrigerators meet energy-saving demands of clinical facilities
Clinicians working across blood banking and transfusion applications can now reduce the environmental footprint of their operations by selecting certified energy-efficient refrigerators that have received a U.S. Environmental Protection Agency (EPA) ENERGY STAR label. The Thermo Scientific TSX Series High-Performance Blood Bank Refrigerators have been recognized by the U.S. EPA...
Eurofins Scientific (EUFI.PA), a world leader in bioanalytical testing, has announced plans to establish a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland as part of a £4 million investment.
The announcement follows Eurofins’ acquisition of Exova’s pharmaceutical, food and water testing business in the UK & Ireland in July 2016, and the subsequent purchase of ILS’s pharmaceutical business in October 2016. Significantly increasing its capacity in the UK, the 5800 m2 facility at Brucefield Industry Park will house Eurofins’ Biopharmaceutical Testing business in the UK...
Cambridge Epigenetix, a pioneer in the development and application of epigenetic technologies, today announces the formation of its Scientific Advisory Board (SAB).
The SAB comprises experts for Cambridge Epigenetix’s key focus areas, including oncology, liquid biopsy and ageing. They form a key strategic resource and provide their unique research perspectives as the company transitions towards becoming an integrated commercial epigenetic biomarker discovery venture....
Uniqsis Ltd., specialists in flow chemistry, has announced a 50% growth in sales and a significant increase in trading profit for their business year ending 31st January 2017.
During the year – Uniqsis achieved strongest growth in North America and Europe with a notable increase in sales of its high performance FlowSyn integrated continuous flow reactor systems for pharmaceutical, nanomaterials and academic research applications....
Partnership aims to identify non-invasive VOC biomarkers in development of live biotherapeutics for disease diagnosis and patient stratification
Owlstone Medical, a diagnostics company developing a breathalyzer for disease, today announced it has signed a master service agreement with 4D Pharma plc (AIM:DDDD), a pharmaceutical company focusing on the development of live biotherapeutics....
Linkam Scientific Instruments, have been chosen by JPK Instruments to supply a customized version of one of their cryo-stage systems to enable surface properties to be studied over an extended temperature range.
Linkam has been developing cryo stages for correlative microscopies for many years while JPK Instruments is regarded as a leading supplier of nanoscale resolution SPM & Optical Tweezer systems. Bringing their technologies together has enabled JPK to offer cryo-stage capability for their NanoWizard® AFM systems. This means AFM users may now study surface property changes as a function of temperature over the range of -120 °C to +220 °C. Head of Applications at JPK...
We have aimed to create a clear and tidy impression.
The website has been redesigned in line with the latest website trends and conventions. With this face-lift, our new website is now state-of-the-art and ready for the new era of the Web. Another key theme of the relaunch was “responsive web design”. The screen display and resolution now automatically adjusts to the different requirements of mobile devices such as smartphones or tablets....
CHROMSOC’S SPRING SYMPOSIUM 2017 on Supercritical Fluid & Ultra-High PerformanceChromatography 15th,16th & 17th May 2017
This symposium will feature oral presentations by leading practitioners of SFC and uHPLC. The latest innovations and applications will be described and the lectures will be augmented and supported by a comprehensive table top exhibition of instrumentation and consumables. Poster presentations will also be invited.
New premises to support growth in customer delivery and support opened by International Trade Minister
Ellutia Chromatography Solutions, the world-renowned gas chromatography instruments and solutions company, officially opened its new state-of-the-art facility in Lancaster Way Business Park, Ely, on 28th February 2017, consolidating its offices, laboratories, production and warehouse on one site....
Analytik Jena has entered a partnership with Illumina, Inc. headquartered in San Diego.
In so doing Analytik Jena gains access to the growing genotyping market currently being served by Illumina’s technologies by offering a production scale solution to provide ultra-high throughput sample preparation in support of Illumina’s enhanced 96-sample Infinium® XT BeadChip.....
Isogenica Ltd, a leader in the design and construction of innovative and highly diverse synthetic antibody libraries, has announced a new licensing deal with a top-25 global pharmaceutical company which specialises in immunology, oncology and immuno-oncology biopharmaceuticals.
Under the terms of the agreement, Isogenica has granted its licensee licences to its family of llamdA™ VHH single-domain antibody libraries for the discovery, development and commercialisation of therapeutic products derived from these libraries. Isogenica is entitled to an upfront and annual licence payments....
ERT, a global data and technology company that minimizes risk and uncertainty in clinical trials, today announced that Premier Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite as its trial management solution.
Clinical trials are becoming increasingly complex, due in part to an array of circumstances including the use of multiple data capture modalities and the need to evaluate more study endpoints than ever before. Additionally, global trials continue to be managed by a growing number of stakeholders, which heightens risks and uncertainties....
Tecan has extended its OEM product portfolio through the acquisition of the PBC, PSR and PBR piston pumps from Pulssar Technologies.
These long life, high precision products are ideal for the automation of dispensing and pipetting tasks in life sciences instrumentation, and perfectly complement the Tecan Cavro® range of syringe pumps and pipetting solutions. This gives instrument designers an even broader choice of liquid handling technologies – as well as an array of robotic and valve options....
Read MoreGround Breaking Multi-Disciplinary Project could Lead to New Targeted Therapies for CancerMar 28, 2017
Fujitsu, Insight Centre for Data Analytics and Systems Biology Ireland partner to develop an automated engine for predicting phosphorylation reactions, important building blocks of cellular signalling networks that can be used for developing new cancer therapies
Recent biomedical research shows that many serious diseases – in particular cancer – are caused by persistent disruptions of cellular communication processes. These processes use a biochemical reaction called phosphorylation to control the information flow. This biochemical computer is faulty in cancer, and drugs that block rogue phosphorylation reactions have proven effective cancer treatments....
Huber’s market growth at is being supported by doubling the production capacity at the Offenburg production site. Construction work on new production facilities and an administration building have already started. Furthermore, the Supervisory Board of Peter Huber Kältemaschinenbau AG agreed to and adopted the suggestion of the Board to acquire the company “Van-der-Heijden Labortechnik GmbH”.....
Hamilton Robotics and Zymo Research Corporation announced an ongoing collaboration that unites Zymo Research’s epigenetics innovations with Hamilton’s high-throughput workflow expertise. A number of Zymo Research assay chemistries are now optimized for use on Hamilton’s automated liquid handling workstations....
The global Preparative and Process Chromatography market is categorized on the basis of products and services, end user, and geography. The service segment is expected to register the highest growth rate in the Preparative and Process Chromatography market, by products and services, during the forecast period....
Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced an investment from Aviva Ventures, the venture capital arm of Aviva plc, a global leader in insurance. The investment takes Owlstone Medical’s total funding to $23.5 million USD (£19.3 million GBP) since its spin-out from Owlstone Inc in 2016....
Lophius Biosciences GmbH today announced the extension of the first tranche of the recently closed financing round by €5.2m to €7.4m. The extension round was led by VRD GmbH, one of the current main investors, supported by the Bavarian Growth Fund (“Wachstumsfonds Bayern”) of Bayern Kapital GmbH and the private investor Wolf Biotech GmbH....
Together with the site owners, Charnwood Campus, and the Leicester and Leicestershire Enterprise Partnership, the University of Leicester is seeking to establish a new Innovation Centre at the UK’s first ever Life Sciences Opportunity Zone in Charnwood, near Loughborough, to accelerate business growth for the Med-Tech and Biopharma community....
AmplyCell's Cell Fitness Technologies, which include BOOST, consist of a four-stage process to optimise cell lines in terms of stability and productivity. Cell lines can be stimulated using AmplyCell's Cell Fitness Technologies at any stage of cell line development or bioproduction (clone creation, RCB/DCB, MCB), without the need to change culture conditions.
Clinicians working across blood banking and transfusion applications can now reduce the environmental footprint of their operations by selecting certified energy-efficient refrigerators that have received a U.S. Environmental Protection Agency (EPA) ENERGY STAR label. The Thermo Scientific TSX Series High-Performance Blood Bank Refrigerators have been recognized by the U.S. EPA...
The announcement follows Eurofins’ acquisition of Exova’s pharmaceutical, food and water testing business in the UK & Ireland in July 2016, and the subsequent purchase of ILS’s pharmaceutical business in October 2016. Significantly increasing its capacity in the UK, the 5800 m2 facility at Brucefield Industry Park will house Eurofins’ Biopharmaceutical Testing business in the UK...
The SAB comprises experts for Cambridge Epigenetix’s key focus areas, including oncology, liquid biopsy and ageing. They form a key strategic resource and provide their unique research perspectives as the company transitions towards becoming an integrated commercial epigenetic biomarker discovery venture....
During the year – Uniqsis achieved strongest growth in North America and Europe with a notable increase in sales of its high performance FlowSyn integrated continuous flow reactor systems for pharmaceutical, nanomaterials and academic research applications....
Linkam has been developing cryo stages for correlative microscopies for many years while JPK Instruments is regarded as a leading supplier of nanoscale resolution SPM & Optical Tweezer systems. Bringing their technologies together has enabled JPK to offer cryo-stage capability for their NanoWizard® AFM systems. This means AFM users may now study surface property changes as a function of temperature over the range of -120 °C to +220 °C. Head of Applications at JPK...
The website has been redesigned in line with the latest website trends and conventions. With this face-lift, our new website is now state-of-the-art and ready for the new era of the Web. Another key theme of the relaunch was “responsive web design”. The screen display and resolution now automatically adjusts to the different requirements of mobile devices such as smartphones or tablets....
Ellutia Chromatography Solutions, the world-renowned gas chromatography instruments and solutions company, officially opened its new state-of-the-art facility in Lancaster Way Business Park, Ely, on 28th February 2017, consolidating its offices, laboratories, production and warehouse on one site....
In so doing Analytik Jena gains access to the growing genotyping market currently being served by Illumina’s technologies by offering a production scale solution to provide ultra-high throughput sample preparation in support of Illumina’s enhanced 96-sample Infinium® XT BeadChip.....
Under the terms of the agreement, Isogenica has granted its licensee licences to its family of llamdA™ VHH single-domain antibody libraries for the discovery, development and commercialisation of therapeutic products derived from these libraries. Isogenica is entitled to an upfront and annual licence payments....
Clinical trials are becoming increasingly complex, due in part to an array of circumstances including the use of multiple data capture modalities and the need to evaluate more study endpoints than ever before. Additionally, global trials continue to be managed by a growing number of stakeholders, which heightens risks and uncertainties....
These long life, high precision products are ideal for the automation of dispensing and pipetting tasks in life sciences instrumentation, and perfectly complement the Tecan Cavro® range of syringe pumps and pipetting solutions. This gives instrument designers an even broader choice of liquid handling technologies – as well as an array of robotic and valve options....
Recent biomedical research shows that many serious diseases – in particular cancer – are caused by persistent disruptions of cellular communication processes. These processes use a biochemical reaction called phosphorylation to control the information flow. This biochemical computer is faulty in cancer, and drugs that block rogue phosphorylation reactions have proven effective cancer treatments....